Jasper Therapeutics, Inc. (JSPR)
Total Valuation
JSPR has a market cap or net worth of $420.13 million. The enterprise value is $335.61 million.
Market Cap | 420.13M |
Enterprise Value | 335.61M |
Important Dates
The last earnings date was Monday, March 4, 2024, before market open.
Earnings Date | Mar 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
JSPR has 15.06 million shares outstanding. The number of shares has increased by 186.15% in one year.
Shares Outstanding | 15.06M |
Shares Change (YoY) | +186.15% |
Shares Change (QoQ) | +0.72% |
Owned by Insiders (%) | 6.15% |
Owned by Institutions (%) | 55.85% |
Float | 10.22M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.36 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.19, with a Debt / Equity ratio of 0.04.
Current Ratio | 7.19 |
Quick Ratio | n/a |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -63.20% and return on invested capital (ROIC) is -84.78%.
Return on Equity (ROE) | -63.20% |
Return on Assets (ROA) | -55.10% |
Return on Capital (ROIC) | -84.78% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.43M |
Employee Count | 45 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.34% in the last 52 weeks. The beta is 2.18, so JSPR's price volatility has been higher than the market average.
Beta (1Y) | 2.18 |
52-Week Price Change | +55.34% |
50-Day Moving Average | 19.98 |
200-Day Moving Average | 12.28 |
Relative Strength Index (RSI) | 69.05 |
Average Volume (30 Days) | 132,205 |
Short Selling Information
The latest short interest is 327,297, so 2.17% of the outstanding shares have been sold short.
Short Interest | 327,297 |
Short Previous Month | 288,859 |
Short % of Shares Out | 2.17% |
Short % of Float | 3.20% |
Short Ratio (days to cover) | 2.16 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -68.86M |
Pretax Income | -64.47M |
Net Income | -64.47M |
EBITDA | -62.94M |
EBIT | -64.47M |
Earnings Per Share (EPS) | -$6.18 |
Balance Sheet
The company has $87.30 million in cash and $2.79 million in debt, giving a net cash position of $84.52 million or $5.61 per share.
Cash & Cash Equivalents | 87.30M |
Total Debt | 2.79M |
Net Cash | 84.52M |
Net Cash Per Share | $5.61 |
Equity / Book Value | 78.44M |
Book Value Per Share | 5.21 |
Working Capital | 76.56M |
Cash Flow
In the last 12 months, operating cash flow was -$52.07 million and capital expenditures -$267,000, giving a free cash flow of -$52.33 million.
Operating Cash Flow | -52.07M |
Capital Expenditures | -267,000 |
Free Cash Flow | -52.33M |
FCF Per Share | -$5.01 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
JSPR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -186.15% |
Shareholder Yield | -186.15% |
Earnings Yield | -15.34% |
FCF Yield | -12.46% |
Analyst Forecast
The average price target for JSPR is $64.75, which is 120.54% higher than the current price. The consensus rating is "Buy".
Price Target | $64.75 |
Price Target Difference | 120.54% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 4, 2024. It was a reverse split with a ratio of 1:10.
Last Split Date | Jan 4, 2024 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |